Viewing Study NCT04906434


Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2026-01-01 @ 5:46 AM
Study NCT ID: NCT04906434
Status: RECRUITING
Last Update Posted: 2025-11-12
First Post: 2021-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
Sponsor: Abbisko Therapeutics Co, Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module